S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Better Than Oil Stocks (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Better Than Oil Stocks (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Better Than Oil Stocks (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
Better Than Oil Stocks (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
NASDAQ:HLVX

HilleVax (HLVX) Stock Forecast, Price & News

$13.45
-0.03 (-0.22%)
(As of 09/29/2023 ET)
Compare
Today's Range
$13.20
$13.58
50-Day Range
$11.59
$15.58
52-Week Range
$11.35
$23.10
Volume
46,199 shs
Average Volume
88,393 shs
Market Capitalization
$651.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HilleVax MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
6.71% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.74mentions of HilleVax in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($3.30) to ($3.51) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.90 out of 5 stars

Medical Sector

960th out of 972 stocks

Biological Products, Except Diagnostic Industry

154th out of 156 stocks


HLVX stock logo

About HilleVax (NASDAQ:HLVX) Stock

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

HLVX Price History

HLVX Stock News Headlines

Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
HilleVax (NASDAQ:HLVX) Shares Down 2.9%
Why HilleVax Shares Are Trading Lower
Pre-market Movers: SPRY, SNTG, PODC, EXAI, BJDX…
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
HilleVax Announces Proposed Public Offering of Common Stock
HilleVax GAAP EPS of -$0.74
Stifel Nicolaus Sticks to Its Buy Rating for HilleVax, Inc (HLVX)
Stifel Nicolaus Reaffirms Their Buy Rating on HilleVax, Inc (HLVX)
J.P. Morgan Keeps Their Buy Rating on HilleVax, Inc (HLVX)
HilleVax: Q1 Earnings Insights
See More Headlines
Receive HLVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HilleVax and its competitors with MarketBeat's FREE daily newsletter.

HLVX Company Calendar

Last Earnings
8/14/2023
Today
10/01/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HLVX
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

Net Income
$-159,810,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$8.01 per share

Miscellaneous

Free Float
34,231,000
Market Cap
$651.25 million
Optionable
Not Optionable
Beta
0.03
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Robert M. Hershberg M.D.Dr. Robert M. Hershberg M.D. (Age 61)
    Ph.D., Pres, CEO & Chairman
    Comp: $1.02M
  • Mr. Aditya Kohli Ph.D. (Age 35)
    COO & Director
    Comp: $782.44k
  • Mr. David A. SocksMr. David A. Socks (Age 48)
    Chief Bus. Officer
    Comp: $709.59k
  • Mr. Shane A. Maltbie (Age 41)
    CFO & Treasurer
  • Dr. Anju Chatterji Ph.D.
    Chief Technology Officer
  • Mr. Paul S. Bavier J.D. (Age 51)
    Gen. Counsel, Sec. & Chief Admin. Officer
  • Ms. Astrid Borkowski M.D. (Age 53)
    Ph.D., Chief Medical Officer
  • Mr. Ozzie Berger
    Sr. VP of Regulatory Affairs













HLVX Stock - Frequently Asked Questions

How have HLVX shares performed in 2023?

HilleVax's stock was trading at $16.73 at the beginning of 2023. Since then, HLVX stock has decreased by 19.6% and is now trading at $13.45.
View the best growth stocks for 2023 here
.

Are investors shorting HilleVax?

HilleVax saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 672,000 shares, an increase of 5.8% from the August 31st total of 635,100 shares. Based on an average daily trading volume, of 58,000 shares, the days-to-cover ratio is presently 11.6 days. Currently, 6.7% of the shares of the company are sold short.
View HilleVax's Short Interest
.

When is HilleVax's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our HLVX earnings forecast
.

How were HilleVax's earnings last quarter?

HilleVax, Inc. (NASDAQ:HLVX) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.74) earnings per share for the quarter, topping analysts' consensus estimates of ($0.85) by $0.11.

What ETFs hold HilleVax's stock?

ETFs with the largest weight of HilleVax (NASDAQ:HLVX) stock in their portfolio include Morningstar US Small Growth (MSGR).ETFMG Treatments Testing and Advancements ETF (GERM).

When did HilleVax IPO?

(HLVX) raised $200 million in an initial public offering (IPO) on Friday, April 29th 2022. The company issued 11,765,000 shares at a price of $16.00-$18.00 per share.

What is HilleVax's stock symbol?

HilleVax trades on the NASDAQ under the ticker symbol "HLVX."

How do I buy shares of HilleVax?

Shares of HLVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HilleVax's stock price today?

One share of HLVX stock can currently be purchased for approximately $13.45.

How much money does HilleVax make?

HilleVax (NASDAQ:HLVX) has a market capitalization of $651.25 million. The company earns $-159,810,000.00 in net income (profit) each year or ($2.46) on an earnings per share basis.

How can I contact HilleVax?

The official website for the company is www.hillevax.com. The company can be reached via phone at 617-213-5054 or via email at ir@hillevax.com.

This page (NASDAQ:HLVX) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -